ResearcherNo recent work listed

Gao Huang

Provisional: name only (low confidence, 0.40), identity_conf@1As of 7 November 2026

Known by name only; no external author ID or institution yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer. Last author DOI 10.3389/fendo.2023.1093042 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuan-Shu Lian · 1 shared paper, 2023 · strength 0.18
- Paper ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer. DOI 10.3389/fendo.2023.1093042 ↗
Wenbo Zou · 1 shared paper, 2023 · strength 0.18
- Paper ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer. DOI 10.3389/fendo.2023.1093042 ↗
Hao Wang · 1 shared paper, 2023 · strength 0.18
- Paper ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer. DOI 10.3389/fendo.2023.1093042 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.